Philipp Mourikis (Amin Polzin)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 7

Top Topics

Atrial Fibrillation

St Segment Elevation Myocardial Infarction

Percutaneous Coronary Intervention

Angiotensin Converting Enzyme

Top Venues

Journal of the American Heart Association

European journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Philipp Mourikis, Amin Polzin
Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? Journal of the American Heart Association 12 (2) (2023)
Philipp Mourikis, Amin Polzin
Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? Journal of the American Heart Association 12 (2) (2023)
Philipp Mourikis, Amin Polzin
Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? Journal of the American Heart Association 12 (2) (2023)
Philipp Mourikis, Amin Polzin
Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? Journal of the American Heart Association 12 (2) (2023)
Philipp Mourikis, Amin Polzin
Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? Journal of the American Heart Association 12 (2) (2023)
Philipp Mourikis, Amin Polzin
Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: How Short Is Too Short? Journal of the American Heart Association (2023)
Carolin Helten, Philipp Mourikis, Lisa Dannenberg, René M'Pembele, Kajetan Trojovsky, Aysel Ayhan, Christina Kohlmorgen, Maria Grandoch, Bodo Levkau, Verena Veulemans, Tobias Petzold, Thomas Hohlfeld, Malte Kelm, Tobias Zeus, Philipp Mourikis
A novel mechanism of ACE inhibition-associated enhanced platelet reactivity: disproof of the ARB-MI paradox? European journal of clinical pharmacology 76 (9) (2020)